Bernhard Hoffmann - Jan 10, 2023 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role
SVP of Corp. Dev. & Ops & Sec.
Signature
/s/ Emily J. Johns, by Power of Attorney
Stock symbol
OCUP
Transactions as of
Jan 10, 2023
Transactions value $
$0
Form type
4
Date filed
1/12/2023, 04:33 PM
Previous filing
Feb 1, 2022
Next filing
Jan 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Award $0 +46.6K +46.55% $0.00 147K Jan 10, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUP Employee Stock Option (right to buy) Award $0 +69.9K $0.00 69.9K Jan 10, 2023 Common Stock 69.9K $3.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 10, 2023.
F2 The option will vest with respect to 17,478 shares on January 10, 2024, with the balance vesting quarterly in twelve equal installments thereafter.